Terfenadine (Triludan - Merrell) and astemizole (Hismanal - Janssen) are two chemically unrelated oral H1-receptor antihistamines marketed recently for the relief of allergic rhinitis, conjunctivitis and other manifestations of histamine release, such as urticaria. Both are claimed to be free of the usual anticholinergic and CNS effects, especially sedation, which limit the use of other H1 antihistamines. If this major claim justified?
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.